TrialCNS drugs2024

SAFE-ROCK: A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants.

Andreas W Wolff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.